By
Latest Stories
Don’t miss our hot and upcoming stories
How Unlearn AI and APST Research Are Revolutionizing Phase II and III Neuroscience Clinical Trials Using AI
December 11, 2024 Enhancing Phase II and III Trials by Increasing Statistical Power and Reducing…
Can BigHat and Johnson & Johnson’s AI-Driven Antibody Alliance Reshape Neuroscience Drug Discovery?
Key Takeaways A Strategic Leap: BigHat Joins Forces with Johnson & Johnson for Neuroscience InnovationBigHat…
Endoscopic AI: How Are Medtronic & Cosmo Pharmaceuticals Shaping the Future of AI in Endoscopic Care?
Dublin, Ireland – April 12, 2024 — Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) and…
PostEra and Pfizer’s AI Lab Accelerates Drug Discovery, Achieving Milestones 40% Faster
Boston – March 27, 2024 Advancing AI-Driven Drug Discovery PostEra has provided an update on…